Intratumoral Administration of Recombinant Murine Interleukin-12 Prevents Tumor Progression and Bone Invasion.

Kasahara S, Kashiwagi M, Inubushi T, Sugauchi A, Deyong W, Kurioka K, Miyagawa K, Matsuda T, Seki S, Kogo M, Tanaka S, Uchihashi T.

Open source

DOI
10.1111/odi.70399
Published
2026-09-02
Container
Oral Dis
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/odi.70399,
  title = {Intratumoral Administration of Recombinant Murine Interleukin-12 Prevents Tumor Progression and Bone Invasion.},
  author = {Kasahara S and  Kashiwagi M and  Inubushi T and  Sugauchi A and  Deyong W and  Kurioka K and  Miyagawa K and  Matsuda T and  Seki S and  Kogo M and  Tanaka S and  Uchihashi T.},
  year = {2026},
  journal = {Oral Dis},
  doi = {10.1111/odi.70399},
  url = {https://doi.org/10.1111/odi.70399}
}

RIS

TY  - JOUR
TI  - Intratumoral Administration of Recombinant Murine Interleukin-12 Prevents Tumor Progression and Bone Invasion.
AU  - Kasahara S
AU  -  Kashiwagi M
AU  -  Inubushi T
AU  -  Sugauchi A
AU  -  Deyong W
AU  -  Kurioka K
AU  -  Miyagawa K
AU  -  Matsuda T
AU  -  Seki S
AU  -  Kogo M
AU  -  Tanaka S
AU  -  Uchihashi T.
PY  - 2026
JO  - Oral Dis
DO  - 10.1111/odi.70399
UR  - https://doi.org/10.1111/odi.70399
ER  - 

APA

S, K., M, K., T, I., A, S., W, D., K, K., K, M., T, M., S, S., M, K., S, T., & T., U. (2026). Intratumoral Administration of Recombinant Murine Interleukin-12 Prevents Tumor Progression and Bone Invasion.. Oral Dis. https://doi.org/10.1111/odi.70399

Source records